E. Clarke Haley
Professor, Neurology
School Of Medicine, 2001 McKim Hall
Bio & Overview
Academic Information
- Department
- Neurology
Research Interests
Selected Publications
2017
Haley, E. C. J. (2017). With a Little Help From My Friends Seeking Consistent and Persuasive Evidence. STROKE, 48(8), 2326-2328. doi:10.1161/STROKEAHA.117.017244
2016
Lyden, P., Weymer, S., Coffey, C., Cudkowicz, M., Berg, S., O'Brien, S., . . . Pryor, K. (2016). Selecting Patients for Intra-Arterial Therapy in the Context of a Clinical Trial for Neuroprotection. STROKE, 47(12), 2979-2985. doi:10.1161/STROKEAHA.116.013881
Huang, X., MacIsaac, R., Thompson, J. L. P., Levin, B., Buchsbaum, R., Haley, E. C. J., . . . Muir, K. W. (2016). Tenecteplase versus alteplase in stroke thrombolysis: An individual patient data meta-analysis of randomized controlled trials. INTERNATIONAL JOURNAL OF STROKE, 11(5), 534-543. doi:10.1177/1747493016641112
2015
Huang, X., Fulton, R., Parsons, M., Levi, C., Campbell, B., Bladin, C., . . . Muir, K. W. (2015). Tenecteplase versus alteplase in acute ischemic stroke thrombolysis: A meta-analysis of individual patient data from randomized studies. INTERNATIONAL JOURNAL OF STROKE, 10, 20. Retrieved from https://www.webofscience.com/
2014
Khatri, P., Yeatts, S. D., Mazighi, M., Broderick, J. P., Liebeskind, D. S., Demchuk, A. M., . . . Tomsick, T. A. (2014). Time to angiographic reperfusion and clinical outcome after acute ischaemic stroke: an analysis of data from the Interventional Management of Stroke (IMS III) phase 3 trial. LANCET NEUROLOGY, 13(6), 567-574. doi:10.1016/S1474-4422(14)70066-3
2013
Wintermark, M., Albers, G. W., Broderick, J. P., Demchuk, A. M., Fiebach, J. B., Fiehler, J., . . . Warach, S. J. (2013). Acute Stroke Imaging Research Roadmap II. STROKE, 44(9), 2628-2639. doi:10.1161/STROKEAHA.113.002015
2011
Levin, B., Thompson, J. L. P., Chakraborty, B., Levy, G., MacArthur, R., & Haley, E. C. (2011). Statistical aspects of the TNK-S2B trial of tenecteplase versus alteplase in acute ischemic stroke: an efficient, dose-adaptive, seamless phase II/III design. CLINICAL TRIALS, 8(4), 398-407. doi:10.1177/1740774511410582
2010
Haley, E. C. J., Thompson, J. L. P., Grotta, J. C., Lyden, P. D., Hemmen, T. G., Brown, D. L., . . . Levin, B. (2010). Phase IIB/III Trial of Tenecteplase in Acute Ischemic Stroke Results of a Prematurely Terminated Randomized Clinical Trial. STROKE, 41(4), 707-711. doi:10.1161/STROKEAHA.109.572040
Haley, E. C., Thompson, J. L., Grotta, J. C., Lyden, P. D., Hemmen, T. M., Brown, D. L., . . . Levin, B. (2010). Phase IIB Trial of Tenecteplase in Acute Stroke. STROKE, 41(4), E332. Retrieved from https://www.webofscience.com/